Comparison of Outcomes and Safety of "Facilitated" Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 103, Issue 3, 2009, Pages 316-321

  McKay, Raymond G ^a   Dada, Marcin R ^a   Mather, Jeffrey F ^a   Mennet, Roger R ^a   Murphy, Deborah J ^a   Maloney, Krista W ^a   Hirst, Jeffrey A ^a   Kiernan, Francis J ^a  

^a HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; TENECTEPLASE; TICLOPIDINE; TIROFIBAN;

ADULT; ADVERSE OUTCOME; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REPEAT PROCEDURE; ST SEGMENT ELEVATION; STROKE; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 58749085398     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.09.078     Document Type: Article

References (18)

1. The ASSENT-4 Investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial. Lancet 367 (2006) 569-678
2. Ellis S.G., Tendera M., de Belder M.A., van Boven A.J., Widimsky P., Janssens L., Andersen H.R., Betriu A., Savonitto S., Adamus J., et al., FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 358 (2008) 2205-2217
3. Keeley E.C., Boura J.A., and Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomized trials. Lancet 367 (2006) 579-588
4. Cannon C.P., Battler A., Brindis R.G., Cox J.L., Ellis S.G., Every N.R., Flaherty J.T., Harrington R.A., Krumholz H.M., Simoons M.L., et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. J Am Coll Cardiol 38 (2001) 2114-2130
5. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., and Ludbrro P. Thrombolysis In Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76 (1987) 142-154
6. Topol E.J., Califf R.M., George B.S., Kereiakes D.J., Abbottsmith C.W., Candela R.J., Lee K.L., Pitt B., Stack R.S., and O'Neill W.W. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317; (1987) 581-588
7. The TIMI Study Group. Comparison of invasive and conservative strategies following intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) II Trial. N Engl J Med 320 (1989) 618-628
8. de Bono D. The European cooperative study group trial of intravenous recombinant tissue-type plasminogen activator (rt-PA) and conservative therapy versus rt-PA and immediate coronary angioplasty. J Am Coll Cardiol 12 (1988) 20A-23A
9. Ross A.M., Coyne K.S., Reiner J.S., Greenhouse S.W., Fink C., Frey A., Moreyra E., Traboulsi M., Racine N., Riba A.L., et al., PACT Investigators. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT Trial. J Am Coll Cardiol 34 (1999) 1954-1962
10. Schweiger M.J., Cannon C.P., Murphy S.A., Gibson C.M., Cook J.R., Giugliano R.P., Changezi H.U., Antman E.M., Braunwald E., and TIMI 10B and TIMI 14 Investigators. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). Am J Cardiol 88 (2001) 831-836
11. Herrman H.C., Moliterno D.J., Ohman E.M., Stebbins A.L., Bode C., Betriu A., Forycki F., Miklin J.S., Bachinsky W.B., Lincoff A.M., Califf R.M., and Topol E.J. Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction. Results from the SPEED (GUSTO-4 Pilot) trial. J Am Coll Cardiol 36 (2000) 1489-1496
12. Widimsky P., Groch L., Zelizko M., Aschermann M., Bednar F., and Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study. Eur Heart J 21 (2000) 823-831
13. Scheller B., Hennen B., Hammer B., Walle J., Hofer C., Hilpert V., Winter H., Nickenig G., Bohm M., and SIAM III Study Group. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol 42 (2003) 634-641
14. Fernandez-Aviles F. Routine invasive strategy within 24 hours of thrombolysis versus ischemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomized controlled trial. Lancet 364 (2004) 1045-1053
15. Le May M.R., Wells G.A., Labinaz M., Davies R.F., Turek M., Leddy D., Maloney J., McKibbin T., Quinn B., Beanlands R.S., et al. Combined Angioplasty and Pharmacological Intervention versus Thrombolysis Alone in Acute Myocardial Infarction (CAPITAL AMI Study). J Am Coll Cardiol 46 (2005) 417-424
16. Fernandez-Aviles F., Alonso J.J., Pena G., Blanco J., Alonso-Briales J., Lopez-Mesa J., Fernandez-Vazquez F., Moreu J., Hernandez R.A., Castro-Beiras A., and GRACIA-2 Investigators. Primary angioplasty versus early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 28 (2007) 949-960
17. ADVANCE MI Investigators. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results from the prematurely terminated Addressing the Value of facilitated Angioplasty after Combination therapy or Eptifibitide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial. Am Heart J 150 (2005) 116-122
18. Kastrati A., Mehilli J., Schlotterbeck K., Dotzer F., Dirshinger J., Schmitt C., Nekolla S.G., Seyfarth M., Martinoff S., Markwardt C., and BRAVE Investigators. Early administration of reteplase plus abciximab versus abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled study. JAMA 291 (2004) 947-954